Longaeva Partners »

Haemonetics Corporation shares owned by Longaeva Partners

Quarter-by-quarter ownership of Haemonetics Corporation (HAE) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Haemonetics Corporation

Tip: Access up to 7 years of quarterly data

All positions including Haemonetics Corporation held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Haemonetics Corporation by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $12M 164k 75.00

More positions owned by Longaeva Partners

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Goldman Sachs Put Option (GS)
JPMorgan Chase & Co. (JPM)
Select Sector Spdr Tr St Str Care Etf Call Option (XLV)
Bank of America Corporation (BAC)
Pfizer Call Option (PFE)
Boston Scientific Corporation Call Option (BSX)
Fifth Third Ban (FITB)
Huntington Bancshares Incorporated (HBAN)
Moody's Corporation (MCO)
Mettler-Toledo International (MTD)
Lpl Financial Holdings (LPLA)
Us Bancorp Com New (USB)
Morgan Stanley Com New (MS)

View all positions for Longaeva Partners

Top funds holding Haemonetics Corporation

BlackRock
Neuberger Berman Group
Vanguard Portfolio Management
AQR Capital Management
Ariel Investments
Vanguard Capital Management
State Street Corporation
Dimensional Fund Advisors
Citadel Advisors
Geode Capital Management
River Road Asset Management
Goldman Sachs Group
Arrowstreet Capital, Limited Partnership
UBS Group
Fort Washington Investment Advisors

View all funds holding Haemonetics Corporation